INTRODUCTION
============

Riboswitches represent gene regulatory systems that consist of a metabolite-responsive aptamer and an overlapping expression platform and are predominantly located in the 5′-untranslated regions (UTRs) of messenger ribonucleic acids (mRNAs) ([@gks616-B1]). Flavin mononucleotide (FMN) is one of the biologically active forms of riboflavin. In bacteria, the synthesis of FMN from riboflavin and adenosine triphosphate is catalyzed by flavokinase (RibC or RibF) ([@gks616-B2]). FMN controls riboflavin biosynthesis in the model bacterium *Bacillus subtilis* by binding the aptamer portion of the *ribG* FMN riboswitch present in the 5′-UTR of the *ribGBAH* mRNA causing transcription termination ([@gks616-B3],[@gks616-B4]). In the Gram-positive bacteria, *Streptomyces davawensis* and *Streptomyces coelicolor* two gene loci responsible for riboflavin biosynthesis (*ribBMAH* and *ribG*) have been identified. The corresponding gene products RibBAH and RibG are similar to the *B. subtilis* enzymes RibGBAH and catalyze the synthesis of riboflavin from guanosine-5′-triphosphate (GTP) and two molecules of ribulose-5′-phosphate ([@gks616-B5]). The gene *ribM* within the *ribBMAH* gene cluster of *S. davawensis* and *S. coelicolor* encodes a riboflavin permease, which is also able to import roseoflavin ([@gks616-B6]). Sequence analysis of *S. coelicolor* and *S. davawensis* revealed that expression of the *ribBMAH* genes may be regulated by an FMN riboswitch (*ribB* FMN riboswitch) ([@gks616-B5]). FMN binding by the *ribB* FMN riboswitch aptamer portion was predicted to prevent initiation of translation of the *ribBMAH*-mRNA by a mechanism involving sequestration of the *ribB* ribosomal binding site ([@gks616-B7]) rather than termination of transcription as observed for the *ribG* FMN riboswitch of *B. subtilis* ([@gks616-B1],[@gks616-B3]).

The antibiotic roseoflavin ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)) is synthesized by *S. davawensis* ([@gks616-B8]) and was found to bind to FMN riboswitches and to affect gene expression ([@gks616-B9; @gks616-B10; @gks616-B11]). Additional support for flavins (or flavin analogs) targeting FMN riboswitches came from structural models for the FMN riboswitch of the Gram-negative bacterium *Fusobacterium nucleatum* bound to riboflavin, FMN and roseoflavin ([@gks616-B12]).

Roseoflavin is the only natural antimetabolite known to affect riboswitches and thus aroused our interest. Understanding the mechanism of roseoflavin resistance of the producer organism, *S. davawensis* was the immediate objective for initiating this study. Beyond that, the results show the unique ability of the *ribB* FMN riboswitch of *S. davawensis* to enhance or reduce gene expression depending on the flavin ligand.

MATERIALS AND METHODS
=====================

Bacterial strains and growth conditions
---------------------------------------

*Streptomyces davawensis* (JCM strain 768) was aerobically grown at 37°C and pH 7.2 in a nutrient broth (YS) containing yeast extract (2 g l^−1^) and soluble potato starch (10 g l^−1^). *Streptomyces coelicolor* was aerobically grown at 30°C in YS. *Escherichia coli* was aerobically cultivated on lysogeny broth (LB) ([@gks616-B13]).

Isolation of total deoxyribonucleic acid and other molecular biology/cloning techniques
---------------------------------------------------------------------------------------

For the isolation of total deoxyribonucleic acid (DNA) from Streptomycetes, a modified protocol of the 'Kirby Mix Procedure' was used ([@gks616-B14]). Other molecular biology techniques were carried out according to standard protocols ([@gks616-B13]).

Chemicals
---------

Riboflavin, FMN and flavin adenine dinucleotide (FAD) were purchased from Sigma (Munich, Germany). Roseoflavin was obtained from Chemos (Regenstauf, Germany)*.* The riboflavin analog 8-demethyl-8-amino riboflavin (AF) was prepared synthetically by Sandro Ghisla (University of Constance, Germany) and was a gift from Peter Macheroux (Graz University of Technology, Austria).

Analysis of flavins
-------------------

Flavins were analyzed by high performance liquid chromatography (HPLC) coupled to a mass spectrometer (Agilent Technologies, Waldbronn, Germany) as described earlier ([@gks616-B15]).

Enzymatic synthesis of flavins
------------------------------

Roseoflavin mononucleotide (RoFMN), roseoflavin adenine dinucleotide (RoFAD) and 8-demethyl-8-amino riboflavin mononucleotide (AFMN) were enzymatically synthesized and purified as described earlier ([@gks616-B15]).

Construction of plasmids used for *in vitro* transcription/translation
----------------------------------------------------------------------

The plasmids for generating transcriptional and translational fusions of FMN riboswitches to the firefly luciferase reporter gene (*luc*) were constructed using pT7luc (Promega, Mannheim, Germany) and a modified version (pT7luc^mod^) ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)). The DNA fragments coding for the different FMN riboswitches were generated by polymerase chain reaction (PCR) using genomic DNA as a template and modifying oligonucleotides ([Supplementary Table S3](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)).

*In vitro* transcription/translation assays
-------------------------------------------

The coupled transcription/translation (TK/TL) assay was performed using the *E. coli* T7 S30 Extract System for Circular DNA Kit (Promega, Mannheim, Germany). Luciferase activity was determined using a microtiter plate reader (Tecan Genios Pro microplate reader, Tecan, Mainz, Germany). *T*~50~ values were estimated by fitting the plot of the luciferase activity percentage versus the flavin concentration using the SigmaPlot 9 software (Systat Software, Erkrath, Germany). The data fit to a first-order exponential decay equation.

Protein concentration determination
-----------------------------------

Protein concentration was estimated by the method of Bradford ([@gks616-B16]).

Measuring riboflavin synthase in Streptomycetes
-----------------------------------------------

Spore suspensions (10^8^ spores) from *S. davawensis* and *S. coelicolor* were used to inoculate 1 l flasks containing 100 ml YS broth, and cultures were grown overnight (14 h). The mycelia were harvested by centrifugation (4000*g*), washed three times and suspended in 100 ml minimal medium. Following a medium change, the cells were grown for another 20, 30 or 40 h and again harvested by centrifugation. The mycelia were washed five times with 100 mM potassium phosphate pH 7.4, suspended in the same buffer and disrupted using a French press (2000 bar, 10°C). The resulting cell extract was tested for riboflavin synthase activity: assay mixtures containing 100 mM potassium phosphate (pH 7.4), 10 mM ethylenediaminetetraacetic acid, 7.5 mM 2-mercaptoethanol and 0.6 mM 6,7-dimethyl-8-ribityllumazine were pre-warmed (5 min, 37°C), and the reaction was started by the addition of cell extracts. Riboflavin formation was monitored by HPLC.

Selection and analysis of spontaneous roseoflavin-resistant *S. coelicolor* mutants
-----------------------------------------------------------------------------------

*Streptomyces coelicolor* spores (10^8^) were spread on mannitol/soya flour (MS) agar containing 200 µM roseoflavin, and the plates were incubated at 30°C for 4 days. The largest (apparently roseoflavin resistant) colonies were isolated and used as an inoculum for 5 ml cultures in YS broth. The isolated strains were aerobically grown for 16 h at 30°C, and cells were harvested by centrifugation. Genomic DNA was extracted from the different isolates using the 'Genomic DNA Extraction Kit' (Fermentas, St. Leon-Rot, Germany) and was used as a template for subsequent PCR reactions. The FMN riboswitch region including the *rib* promoter was amplified by PCR. The resulting PCR products were subjected to DNA sequencing.

In-line probing assay
---------------------

In-line probing assays were performed as described previously ([@gks616-B17]).

Fluorescence measurements
-------------------------

The intensity of fluorescence emission was measured at 535 nm with an excitation at 485 nm. Assays were performed on the basis of the intrinsic fluorescence of FMN and RoFMN, which is quenched on the specific interaction of the flavins with the riboswitch aptamers. RoFMN fluorescence was ∼20 times weaker when compared with FMN. Each experiment was performed three times at 25°C using a Tecan Genios Pro microplate reader. FMN riboswitch RNA molecules (containing both the aptamer and the expression platform) were *in vitro* synthesized by T7 RNA polymerase (Promega, Mannheim) using the plasmids generating translational fusion as templates.

RESULTS
=======

*Streptomyces davawensis* is roseoflavin resistant
--------------------------------------------------

It was reported earlier that roseoflavin inhibits growth of the Gram-positive bacteria *Staphylococcus aureus* (MIC from 0.25 to 6.25 µg ml^−1^), *Bacillus subtilis* (MIC 1.56 µg ml^−1^), *Bacillus cereus and Micrococcus luteus* (*Sarcina lutea*) ([@gks616-B8]). In this work, *S. davawensis* and some closely related species, *Streptomyces lividans*, *Streptomyces coelicolor*, *Streptomyces albus* and *Streptomyces avermitilis* were tested with respect to roseoflavin sensitivity. Spores of *S. lividans*, *S. coelicolor*, *S. albus* and *S. avermitilis* were not able to produce colonies on a solid growth medium containing 200 µM roseoflavin, and we concluded that these bacteria are roseoflavin sensitive ([Figure 1](#gks616-F1){ref-type="fig"}). The three latter species all contain a gene homologous to *S. davawensis ribM*, which was shown to be responsible for riboflavin and roseoflavin uptake ([@gks616-B5],[@gks616-B6]). The *S. lividans* genomic data have not been published yet, and thus, the presence of a *ribM* homologous gene could not be verified. In contrast to the other Streptomycetes, spores of *S. davawensis* were able to germinate and produce colonies in the presence of 200 µM roseoflavin showing that *S. davawensis* is roseoflavin resistant. Notably, RibC homologous enzymes are present in all five Streptomycetes, and it is thus very likely that in these organisms imported flavins (and flavin analogs) are phosphorylated and adenylylated. Figure 1.*Streptomyces davawensis* is roseoflavin resistant. *Streptomyces davawensis* (**a**) and the closely related species *Streptomyces lividans* (**b**), *S. coelicolor* (**c**), *Streptomyces albus* (**d**) and *Streptomyces avermitilis* (**e**) were tested with respect to roseoflavin sensitivity. To each of the sectors of the YS plates, ∼50 000 spores of the different *Streptomyces* species were applied and incubated aerobically for 60 h at 30°C. Only the YS plate to the right contained the antibiotic roseoflavin (200 µM).

RoFMN and RoFAD are present in the cytoplasm of *S. coelicolor* and *S. davawensis*
-----------------------------------------------------------------------------------

*Streptomyces coelicolor* and *S. davawensis* were cultured in the presence of sub-lethal concentrations of roseoflavin (50 µM). Exponentially growing cells were harvested, thoroughly washed and disrupted. Subsequently, the corresponding cell-free extracts were analyzed by liquid chromatography (LC-MS) for their flavin content, which was normalized to the total protein content of the cells. Analysis of *S. coelicolor* cell-free extracts revealed the presence of both RoFMN (1.2 ± 0.3 µM) and RoFAD (0.1 ± 0.05 µM). Similar concentrations of RoFMN/RoFAD were detected in the corresponding cell-free extracts of *S. davawensis* (RoFMN, 1.4 ± 0.2 µM; RoFAD, 0.2 ± 0.06 µM). *Streptomyces davawensis* naturally produces roseoflavin in the stationary growth phase. Correspondingly, it was of interest whether cell-free extracts of stationary cultures not pulsed with roseoflavin-contained RoFMN and RoFAD as well. Indeed, cell free-extracts from these cells were found to contain 0.9 µM RoFMN (±0.1 µM) and 0.1 µM RoFAD (±0.03 µM). Free flavins (riboflavin and roseoflavin) were detected in both bacteria in trace amounts only (\<0.01 µM). Thus, *S. davawensis* is roseoflavin resistant but is not a riboflavin overproducer.

The addition of roseoflavin reduces riboflavin synthase activity in *S. coelicolor* but not in *S. davawensis*
--------------------------------------------------------------------------------------------------------------

Expression of the *ribBMAH* genes was monitored in *S. coelicolor* and in *S. davawensis* cultures by measuring the activity of riboflavin synthase (RibB), the product of the first gene of the cluster catalyzing the last step in riboflavin biosynthesis. RibB activity was measured at different time points (20, 30 and 40 h) following a change of the culture medium and the addition of flavins ([Table 1](#gks616-T1){ref-type="table"}). It was found that on addition of riboflavin to cultures of *S. coelicolor*, RibB activity decreased up to 47.7% when compared with the control level. When roseoflavin was added to the cultures, a stronger decrease of RibB activity was detected (up to 20.7% after 20 h). After 40 h of growth in the presence of roseoflavin, no RibB activity was detected in cells of *S. coelicolor*. In *S. davawensis*, the addition of riboflavin reduced RibB activity up to 23.5%. The addition of roseoflavin, however, had no such effect (RibB activity remained at \>90%) showing that expression of the *ribBMAH* genes in *S. davawensis* was only slightly reduced by this antibiotic. The data ([Table 1](#gks616-T1){ref-type="table"}) also revealed that the specific RibB activity in *S. davawensis* (20 h: 0.485 µM mg^−1 ^h^−1^) was quite similar to what was found in *S. coelicolor* at that time point (20 h: 0.319 µM mg^−1 ^h^−1^). However, in *S. davawensis*, RibB activity strongly increased at 30 h of growth and at 40 h was almost 60 times higher when compared with *S. coelicolor*. Notably, this did not lead to an increased riboflavin level in the cytoplasm of *S. davawensis*. Table 1.Monitoring *ribBMAH* gene expression by measuring the activity of riboflavin synthase (RibB)MM 20 h (µM mg^−1 ^h^−1^)MM 30 h (µM mg^−1 ^h^−1^)MM 40 h (µM mg^−1 ^h^−1^)YS 40 h (µM mg^−1 ^h^−1^)*S. davawensis*    Control0.485 ± 0.0401.862 ± 0.1515.140 ± 0.5020.451 ± 0.050    RF 50 µM0.225 ± 0.0300.614 ± 0.0601.208 ± 0.1000.226 ± 0.018    RoF 50 µM0.474 ± 0.0501.781 ± 0.0704.575 ± 0.3131.168 ± 0.235*S. coelicolor*    Control0.319 ± 0.0150.254 ± 0.0400.088 ± 0.005    RF 50 µM0.176 ± 0.0140.129 ± 0.0110.042 ± 0.003    RoF50 µM0.066 ± 0.0020.053 ± 0.0040MM 20 h (%)MM 30 h (%)MM 40 h (%)YS 40 h (%)*S. davawensis*    Control100 ± 8.2100 ± 8.1100 ± 9.7100 ± 11.0    RF 50 µM46.4 ± 13.333.0 ± 9.723.5 ± 8.350.1 ± 8.0    RoF 50 µM97.7 ± 10.595.6 ± 3.990.0 ± 6.8259.8 ± 20.1*S. coelicolor*    Control100 ± 4.7100 ± 15.7100 ± 5.7    RF 50 µM55.1 ± 7.950.8 ± 8.547.7 ± 7.1    RoF 50 µM20.7 ± 3.020.8 ± 7.50[^1]

When grown on minimal medium, *S. davawensis* produced comparably small concentrations of roseoflavin (1 µM). However, when grown in YS culture medium containing small concentrations (4 µM) of the precursor riboflavin, considerably more roseoflavin (19 µM) was produced by *S. davawensis*. We, therefore, performed similar experiments as described earlier with *S. davawensis* growing in YS. A strongly increased RibB activity (to 259.8%) was detected on addition of roseoflavin to the cultures. In contrast, the addition of riboflavin reduced RibB activity to 50.1%. An increase of RibB activity in *S. davawensis* on stimulation with roseoflavin is perfectly in line with the fact that riboflavin is the precursor of roseoflavin ([@gks616-B18]) and thus is needed in larger concentrations when roseoflavin synthesis is triggered in the stationary growth phase.

The *ribB* FMN riboswitches of *S. davawensis* and *S. coelicolor* regulate at the translational level
------------------------------------------------------------------------------------------------------

To be able to quantify the activity of FMN riboswitches from different bacteria, an *in vitro* transcription/translation assay was established based on the plasmid pT7luc. Between the bacteriophage T7 promoter and the luciferase reporter gene, FMN riboswitches from *B. subtilis*, *S. coelicolor* and *S. davawensis* were placed. Two different plasmid constructs were generated for each FMN riboswitch to be tested producing transcriptional as well as translational fusions ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)). The plasmids were used as templates in a T7 RNA polymerase based *in vitro* transcription/translation assay. Before analyzing the yet uncharacterized *Streptomyces* riboswitches, the assay was validated using the well-characterized *ribG* FMN riboswitch from *B. subtilis*. The presence of FMN in the reaction reduced luciferase gene expression regardless of whether the plasmid generating a transcriptional fusion (reduction to 40%; ±2%) or a translational fusion (reduction to 42%; ±3%) to the reporter gene *luc* was used. Apparently, the *ribG* FMN riboswitch from *B. subtilis* acted at the transcriptional level as was reported earlier ([@gks616-B3], [@gks616-B4]). In contrast, *luc* expression was not reduced when the FMN riboswitches from *S. coelicolor* and *S. davawensis* were tested in the *in vitro* transcription/translation assay using the plasmids generating transcriptional fusions. However, FMN reduced luciferase gene expression using the plasmids for translational fusions: An identical reduction to 40% (±2%) was observed for both Streptomycetes riboswitches. The latter result shows that the FMN riboswitches of *S. davawensis* and *S. coelicolor* indeed regulate at the translational level as was hypothesized earlier ([@gks616-B7]). Similar results were obtained by *in vivo* experiments in *B. subtilis* using transcriptional *lacZ* fusions (data not shown).

RoFMN triggers the *B. subtilis ribG* FMN riboswitch to repress gene expression
-------------------------------------------------------------------------------

It was reported earlier that the bifunctional flavokinase/FAD synthetase of *B. subtilis* (RibC) accepts roseoflavin as a substrate and produces RoFMN and RoFAD ([@gks616-B19]). Moreover, our present data show that the latter cofactor analogs are present in roseoflavin-treated cells. Hence, it seemed feasible that RoFMN (and not roseoflavin) was the true effector of FMN riboswitches. Indeed, the addition of increasing concentrations of RoFMN (0--180 µM) led to reduced Luc activity (by up to 60%) when the *B. subtilis ribG* FMN riboswitch was tested using *in vitro* transcription/translation ([Figure 2](#gks616-F2){ref-type="fig"}a). Notably, a very similar effect was found when FMN was added. The addition of riboflavin and roseoflavin had a much smaller effect. Figure 2.Flavins and their effect on FMN riboswitches. (**a**) A reporter plasmid producing a transcriptional fusion of the *ribG* FMN riboswitch of *Bacillus subtilis,* and the reporter gene *luc* (coding for firefly luciferase) was used as a DNA template for an *in vitro* transcription/translation assay driven by RNA polymerase of bacteriophage T7 ([Supplementary Figure S2a](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)). The addition of FMN resulted in less activity of Luc indicating that less *luc* transcript was produced. RoFMN had a very similar effect. The addition of riboflavin or roseoflavin also resulted in reduced luciferase activity; however, the effect was less pronounced. (**b**) and (**c**) Reporter plasmids producing translational *luc* fusions ([Supplementary Figure S2b](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)) of the *ribB* FMN riboswitches of *S. coelicolor* (b, RFNBcoe) and *S. davawensis* (c, RFNBdav) were used as templates for *in vitro* transcription/translation assays as in (a). Most importantly, in contrast to RFNBdav (c), RFNBcoe (b) was negatively affected by RoFMN. A genome-wide screen for FMN riboswitches in *S. davawensis* identified a second (*ribA*) FMN riboswitch ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)) controlling a gene cluster with unknown function. The activity of the *ribA* FMN riboswitch (RFNAdav, **d**) was tested as described earlier. RFNAdav (in contrast to RFNBdav) was found to be negatively affected by RoFMN. Mean values of three independent experiments are shown. For clarity, standard deviations (SDs) are shown in (a) only.

The *S. coelicolor* and *S. davawensis ribB* FMN riboswitches respond differently to the flavin analogs RoFMN and AFMN
----------------------------------------------------------------------------------------------------------------------

According to the results up to this point, our study suggested that formation of RoFMN targeting FMN riboswitches was responsible for the antibiotic effect of roseoflavin. As *S. davawensis*, in contrast to *S. coelicolor*, was found to be roseoflavin resistant, we hypothesized that the *ribB* FMN riboswitches of the two organisms may react differently with respect to treatment with RoFMN. To test this, the *ribB* FMN riboswitches of *S. coelicolor* and *S. davawensis* were characterized using *in vitro* transcription/translation assays. For the *S. coelicolor* FMN riboswitch, both FMN and RoFMN significantly reduced the amount of luciferase activity *in vitro* ([Figure 2](#gks616-F2){ref-type="fig"}b). FMN induced a reduction by up to 62% (±7%), and for RoFMN, the reduction was up to 75% (±6%). Similar experiments ([Figure 2](#gks616-F2){ref-type="fig"}c) were carried out with the *S. davawensis* riboswitch, and it was found that luciferase activity was strongly reduced on addition of FMN (by up to 63%, ±7%) to the assay. The extent of reduction was similar to what was found for the *S. coelicolor* riboswitch. Most strikingly, however, the addition of RoFMN to the assay containing the *S. davawensis* riboswitch resulted in an increase of luciferase activity by 28% (±9%).

The amount of flavin needed for a 50% reduction (*T*~50~) of luciferase activity in the transcription/translation assays is a measure for the apparent ligand affinity of the FMN riboswitch aptamers and was estimated from the data in [Figure 2](#gks616-F2){ref-type="fig"}. *T*~50~ of the *B. subtilis* aptamer was 46 µM (±6 µM) for FMN and 40 µM (±4 µM) for RoFMN. *T*~50~ of the *S. coelicolor* aptamer was 50 µM (±8 µM) for FMN and 20 µM for RoFMN (±5 µM). *T*~50~ of the *S. davawensis* aptamer was 102 µM (±6 µM) for FMN. For RoFMN, an activation was observed, and thus, *T*~50~ could not be calculated.

The FMN riboswitches from *S. coelicolor* and *S. davawensis* were also tested with respect to modulation by other flavins. 8-Demethyl-8-amino-riboflavin (AF, the 5′-phosphorylated form is AFMN) is the direct precursor of roseoflavin ([@gks616-B20]) and was found to exhibit antibiotic activity as well (M. Mack, unpublished data). In summary, the *S. coelicolor* FMN riboswitch was found to be negatively affected by all flavins tested (roseoflavin, riboflavin, RoFMN, FMN, RoFAD and AFMN) except for FAD ([Figure 2](#gks616-F2){ref-type="fig"}b). Except for FMN, only riboflavin was able to decrease the luciferase activity level when testing the *S. davawensis* riboswitch ([Figure 2](#gks616-F2){ref-type="fig"}c). RoFAD, RoFMN, roseoflavin and AFMN stimulated luciferase gene expression by up to 38% (180 µM RoFAD).

Analysis of a second FMN riboswitch present in the genome of *S. davawensis*
----------------------------------------------------------------------------

A genome-wide screen in *S. davawensis* identified a second sequence element ('*ribA* FMN riboswitch') matching the profile of FMN riboswitch aptamers ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)). The *ribA* FMN riboswitch is present in the 5′-UTR of a gene cluster (comprising seven genes) with unknown function. Interestingly, the product of the first putative gene within this cluster is similar (up to 54% on the amino acid level) to 3,4-dihydroxy-2-butanone 4-phosphate synthases (EC 4.1.99.12) from other microorganisms. The latter enzymes catalyze an initial step in riboflavin biosynthesis, the formation of 3,4-dihydroxy-2-butanone 4-phosphate from ribulose-5-phosphate ([@gks616-B21]).

The *ribA* FMN riboswitch was analyzed using *in vitro* transcription/translation and, in contrast to the *S. davawensis ribB* FMN riboswitch, was found to be negatively affected by both RoFMN (*T*~50~ = 25 ± 4 µM) and FMN (*T*~50~ = 94 ± 5 µM) ([Figure 2](#gks616-F2){ref-type="fig"}d). Besides RoFAD, all the other flavins tested negatively affected expression of the luciferase gene under control of this FMN riboswitch. Only the translational fusion of the *ribA* FMN riboswitch produced a decrease in luciferase activity on FMN addition, strongly suggesting that it also operates at the translational level.

The nucleotide A61 of the *S. davawensis ribB* riboswitch is responsible for discrimination between FMN and RoFMN
-----------------------------------------------------------------------------------------------------------------

The *ribB* FMN riboswitch aptamers of *S. coelicolor* and *S. davawensis* differ at four nucleotide positions only (61, 62, 66 and 74; [Figure 3](#gks616-F3){ref-type="fig"}a and [Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)). Sequence analysis of *ribB* FMN riboswitch aptamers of roseoflavin-sensitive *Streptomyces* species tested in this work (*S. coelicolor*, *S. lividans*, *S. albus* and *S. avermitilis*) revealed that roseoflavin-resistant *S. davawensis* is the only species to contain an A at position 61 ([Figure 3](#gks616-F3){ref-type="fig"}b). Positions 62, 66 and 74 appeared not to be key residues with respect to roseoflavin/RoFMN resistance as *S. coelicolor*, *S. lividans*, *S. avermitilis* and/or *S. albus* FMN riboswitch aptamers share identical nucleotides with the *S. davawensis ribB* riboswitch. Moreover, none of the 23 *Streptomyces* FMN riboswitches listed in the RFAM database ([@gks616-B22]) revealed the nucleotide pair 61AC75 ([Figure 3](#gks616-F3){ref-type="fig"}a). Variants of the riboswitch aptamers of *S. coelicolor* and *S. davawensis* were generated by site-directed mutagenesis and tested using *in vitro* transcription/translation. The single-nucleotide exchange A61G produced a mutant *S. davawensis ribB* FMN riboswitch (RFNBdavA61G), which apparently was negatively affected by both FMN and RoFMN ([Figure 4](#gks616-F4){ref-type="fig"}b). In contrast, the wild-type riboswitch was negatively affected by FMN but found to be more active in the presence of RoFMN ([Figures 4](#gks616-F4){ref-type="fig"}a and [2](#gks616-F2){ref-type="fig"}c). The single-nucleotide exchanges C62T ([Figure 4](#gks616-F4){ref-type="fig"}c) and G74A ([Figure 4](#gks616-F4){ref-type="fig"}e) produced mutant *S. davawensis* FMN riboswitches, which were less sensitive with respect to both FMN and RoFMN indicating that destabilization of the P4 stem ([Figure 3](#gks616-F3){ref-type="fig"}a) affects aptamer/riboswitch function. The exchange T66C responded like the wild type to FMN and RoFMN ([Figure 4](#gks616-F4){ref-type="fig"}d). The mutant *ribB* FMN riboswitches A61G/C62T/G74A ([Figure 4](#gks616-F4){ref-type="fig"}f) and A61G/C62T/T66C/G74A ([Figure 4](#gks616-F4){ref-type="fig"}g; corresponds to the *S. coelicolor* aptamer) both were negatively affected by RoFMN. Most interestingly, the exchange G61A within the *S. coelicolor ribB* FMN riboswitch (removing Watson-Crick base pairing at 61GC75) produced a RoFMN-insensitive riboswitch ([Figure 5](#gks616-F5){ref-type="fig"}h) still responding to FMN. Notably, *S. davawensis* is the only species to contain the nucleotides 261CT262 in the downstream expression platform ([Figure 3](#gks616-F3){ref-type="fig"}c). Figure 3.Comparison of different *Streptomyces* FMN riboswitches. (**a**) Sequence, secondary structure and expected transcriptional intermediates of the 5′-UTR of the *ribB* mRNA from *S. davawensis* \[ribosomal binding site (RBS), nucleotides in red\]. The solid black line represents a highly variable RNA stretch. The key nucleotide pair (61AC75) with respect to RoFMN resistance is boxed. Nucleotides differing to the *S. coelicolor* aptamer are boxed yellow. Nucleotides marked brown are responsible for anti-sequestration. (**b**) Nucleotide sequences of aptamer portions of FMN riboswitches from different Streptomycetes. The aptamers are highly similar and only the nucleotides differing to the *S. davawensis ribB* FMN riboswitch (top sequence) are shown. The *S. davawensis* aptamer is the only sequence containing an A at position 61 (boxed). The other *Streptomyces* species show either a G or a T (U) at this position. A61 is not able to pair with C75 (boxed). (**c**) Nucleotides encompassing the *ribB* ribosomal binding sites (red) of different Streptomycete *ribB* FMN riboswitches are shown. *Streptomyces davawensis* is the only species to contain the nucleotides C and T at positions 261 and 262 (boxed). Figure 4.Nucleotide A61 of the *S. davawensis ribB* FMN riboswitch is responsible for the discrimination between FMN and RoFMN. Reporter plasmids producing translational *luc*-fusions of *ribB* FMN riboswitches from *S. davawensis* and *S. coelicolor* were used as templates for *in vitro* transcription/translation assays ([Figure 2](#gks616-F2){ref-type="fig"}). Wild-type (**a**) and mutant FMN riboswitches of *S. davawensis* (**b--g**) and a mutant FMN riboswitch of *S. coelicolor* (**h**) were tested in the presence of FMN or RoFMN. The single-nucleotide exchange A61G (b) produced an *S. davawensis* FMN riboswitch which, in contrast to the wild-type riboswitch (a), was negatively affected by both FMN and RoFMN. The single-nucleotide exchanges C62T (c), T66C (d) and G74A (e) produced similar results as in (a). Most interestingly, the single mutation G61A within the *S. coelicolor* FMN riboswitch aptamer (removing Watson--Crick DNA base pairing at nucleotide 61G-75C) produced a RoFMN-insensitive FMN riboswitch (h). Mean values of three independent experiments are shown. Figure 5.The *S. davawensis* FMN riboswitch confers roseoflavin resistance to *S. coelicolor.* Spores of different *Streptomyces* strains were applied to each of the sectors of the YS plates shown (1, wild-type *S. davawensis*; 2, wild-type *S. coelicolor*; 3, *S. coelicolor*::pSET152; 4, *S. coelicolor*::pSET152-P~rib~RFNB^dav^*ribBMAH*^dav^ and 5, *S. coelicolor*:: pSET152-P~rib~RFNB^davA61G^*ribBMAH*^dav^), and the plates were aerobically incubated at 30°C for 60 h. The recombinant *S. coelicolor* in sector 4 was generated by introducing the *S. davawensis ribBMAH* cluster into the chromosome of *S. coelicolor* by homologous recombination. The strain in sector 3 is a control containing empty pSET152 at Φ31. The recombinant *S. coelicolor* in sector 5 was generated by introducing the *S. davawensis ribBMAH*-genes (including the roseoflavin-sensitive A61G mutant FMN *ribB* riboswitch). (**a**) The plate to the left contained 200 µM roseoflavin, and the plate to the right did not contain any antibiotic. The spores in sector 5 of the left plate produced less mycelium when compared with the spores in sector 4. (**b**) Growth of the strains *S. coelicolor*::pSET152-P~rib~RFNB^dav^*ribBMAH*^dav^ (solid squares) and *S. coelicolor*::pSET152-P~rib~RFNB^davA61G^*ribBMAH*^dav^ (open squares) was also monitored in a liquid culture (minimal medium). (**c**) Schematic drawing showing the chromosome of recombinant *S. coelicolor* strains containing two different gene clusters controlled by two different promoters (with very similar activity) and two different FMN *ribB* riboswitches (RFNBcoe, from *S. coelicolor*, and RFNBdav from *S. davawensis*).

The *S. davawensis* FMN riboswitch confers roseoflavin resistance to *S. coelicolor*
------------------------------------------------------------------------------------

The following experiment was initiated to *in vivo* validate the *in vitro* results strongly suggesting that a single-nucleotide change conferred roseoflavin/RoFMN resistance to *S. davawensis*. The *S. davawensis ribBMAH* genes including the RoFMN insensitive (wild type) *ribB* FMN riboswitch and the corresponding promoter P*~rib~* were integrated into the chromosome of *S. coelicolor* by homologous recombination at the Φ31 site ([Figure 5](#gks616-F5){ref-type="fig"}c) using pSET152 ([@gks616-B23]). The resulting strain *S. coelicolor*::pSET152-P~rib~RFNB^dav^*ribBMAH*^dav^ was found to be roseoflavin resistant ([Figure 5](#gks616-F5){ref-type="fig"}a). It has long been known that oversynthesis of riboflavin in the cytoplasm compensates for the toxic effect of roseoflavin and results in roseoflavin resistance ([@gks616-B24]). Therefore, it was important to exclude the possibility that increased activities of the products of the chromosomally integrated *S. davawensis ribBMAH* genes (possibly leading to increased riboflavin levels) were responsible for roseoflavin resistance. To exclude this possibility, the *S. davawensis ribBMAH*-genes including the roseoflavin-sensitive A61G mutant FMN riboswitch were chromosomally integrated in *S. coelicolor*. The corresponding recombinant strain *S. coelicolor*::pSET152-P~rib~RFNB^davA61G^*ribBMAH*^dav^ was grown on a solid medium in the presence of roseoflavin, and only sparse growth was observed ([Figure 5](#gks616-F5){ref-type="fig"}a). Similarly, when grown in liquid medium, only little growth was observed ([Figure 5](#gks616-F5){ref-type="fig"}b). The recombinant *S. davawensis* strains were further characterized by measuring cellular riboflavin synthase (RibB) activity ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)). On addition of riboflavin to the culture medium of the roseoflavin-resistant strain *S. coelicolor*::pSET152-P~rib~RFNB^dav^*ribBMAH*^dav^, RibB activity decreased to 42%, whereas roseoflavin addition only caused a small reduction of RibB activity (91%). This experiment showed that *S. coelicolor*::pSET152-P~rib~RFNB^dav^*ribBMAH*^dav^ essentially responded like *S. davawensis* to treatment with roseoflavin. In case of the roseoflavin-sensitive *S. coelicolor*::pSET152-P~rib~RFNB^davA61G^*ribBMAH*^dav^ strain, RibB activity decreased to 58% on addition of riboflavin to the culture medium. An even stronger decrease of RibB activity was found when roseoflavin was added to the cultures (47%), showing that the mutation A61G in the riboswitch leads to a roseoflavin response similar to what was found for *S. coelicolor* wild type. Notably, the total specific RibB activities were very similar in all *S. coelicolor* strains irrespective whether the *S. davawensis ribBMAH* genes (including the *rib* promoter and the FMN riboswitches) were present or not. Furthermore, the *rib* promoters from *S. coelicolor* and *S. davawensis in vivo* had an almost identical activity (data not shown).

A spontaneous roseoflavin-resistant mutant of *S. coelicolor* carries the point mutation G61A within the *ribB* FMN riboswitch
------------------------------------------------------------------------------------------------------------------------------

Spores of wild-type *S. coelicolor* were plated on a growth medium supplemented with roseoflavin and spontaneous roseoflavin-resistant cells (producing colonies) were detected with a frequency of 1 × 10^−8^. The regions upstream of the *ribBMAH* gene clusters (comprising the promoter P*~rib~* and the *ribB* FMN riboswitch) of 20 independent roseoflavin-resistant strains were amplified by PCR and analyzed by DNA sequencing. One of 20 isolated roseoflavin-resistant *S. coelicolor* strains showed the mutation G61A in the FMN riboswitch ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)). The remaining 19 strains did not show mutations in the corresponding 500 bp PCR fragment. The reason for roseoflavin resistance of the latter strains is most likely due to a mutation in *ribC* ([@gks616-B25],[@gks616-B26]).

The FMN riboswitch aptamers of *S. coelicolor* and *S. davawensis* bind FMN and RoFMN with high affinity
--------------------------------------------------------------------------------------------------------

An in-line probing assay ([@gks616-B17]) was used to test *ribB* FMN riboswitch aptamers from *S. coelicolor* and *S. davawensis* for FMN and RoFMN binding. We found that the apparent affinities of the *S. coelicolor* and *S. davawensis ribB* FMN riboswitch aptamers were exceedingly high for FMN and also for RoFMN. Indeed, the *K*~D~ values were so small (*K*~D~ ≪ 5 nM) that they could not reliably be measured with in-line probing. To overcome this, a single mutation was placed in the P1 stem ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)), as it is known that similar mutations in other riboswitches weaken affinities but do not alter ligand specificities ([@gks616-B27]). The *K*~D~ estimates using in-line probing are summarized in the [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1) and revealed that all the FMN riboswitch aptamers tested had a similar affinity for FMN and RoFMN. At first sight, this result with respect to the *S. davawensis ribB* FMN riboswitch aptamer was surprising given the expectation that the *S. davawensis* FMN riboswitch, being not negatively affected by RoFMN in *in vitro* transcription/translation experiments, would contain a metabolite-sensing aptamer with a much higher *K*~D~ value for RoFMN when compared with FMN. The data earlier, however, suggest that the *S. davawensis* aptamer does not selectively discriminate against RoFMN under equilibrium conditions. The control of gene expression mediated by metabolite-sensing riboswitches is predicted to be either thermodynamically or kinetically driven ([@gks616-B27],[@gks616-B28]). For example, it has been shown that the *B. subtilis ribG* FMN riboswitch does not reach thermodynamic equilibrium with FMN in a time frame that is relevant for gene control. Rather, the latter riboswitch is kinetically driven, and therefore, the rate constant for ligand association is more meaningful than the *K*~D~ value when evaluating the concentration of ligand needed to trigger gene control. Our working hypothesis was that the *S. davawensis ribB* riboswitch functions as a kinetically driven riboswitch as well and thus differently responds to FMN/RoFMN on a seconds or minutes timescale ([@gks616-B28]). As in-line probing assays extended for 40 h, this kinetic discrimination effect in the case of the *S. davawensis ribB* FMN riboswitch (i.e. a slower rate of association of RoFMN) may have been masked by a slower off rate of RoFMN when compared with FMN.

The *ribB* FMN riboswitches of *S. davawensis* and *S. coelicolor* operate differently
--------------------------------------------------------------------------------------

Fluorescence measurement assays were conducted to study the basis of the ligand--riboswitch interaction for the *ribB* FMN riboswitches of *S. coelicolor* and *S. davawensis*. The kinetically driven *ribG* FMN riboswitch from *B. subtilis* was used as a control. FMN riboswitch RNAs (aptamer portions in combination with the expression platforms) *in vitro* were synthesized and were incubated in the presence of either FMN (1 µM) or RoFMN (1 µM). As expected ([@gks616-B28]), the *B. subtilis* riboswitch RNA did not induce fluorescence quenching due to ligand (FMN or RoFMN) binding ([Figure 6](#gks616-F6){ref-type="fig"}a and b). In contrast, the presence of the *S. coelicolor* riboswitch RNA led to significant fluorescence quenching of FMN and RoFMN indicating strong binding of both ligands ([Figure 6](#gks616-F6){ref-type="fig"}a and b). The latter result suggested that the *S. coelicolor* riboswitch RNA (in contrast to the *B. subtilis* riboswitch RNA) is able to remain receptive for a considerably longer time, which would allow it to function thermodynamically. Very similar results as for the *B. subtilis ribG* FMN riboswitch were found for the *S. davawensis ribB* FMN riboswitch, which apparently also formed an RNA unable to bind either FMN or RoFMN when it was complete ([Figure 6](#gks616-F6){ref-type="fig"}a and b). We, therefore, tentatively concluded that the *S. davawensis* FMN riboswitch is kinetically driven. Figure 6.Monitoring riboswitch-FMN/RoFMN complex formation by real-time fluorometry. Each image shows the change of fluorescence with time. The measurements were carried out to study ligand binding of the *ribB* FMN riboswitches from *S. coelicolor* (RFNBcoe) and *S. davawensis* (RFNBdav). The kinetically driven *ribG* FMN riboswitch from *B. subtilis* (RFNGbs) was used as a control. Riboswitch RNAs (aptamer portion in combination with the expression platform) *in vitro* were synthesized by T7 RNA polymerase and were incubated in the presence of 1 µM FMN or 1 µM RoFMN. Fluorescence quenching due to FMN (**a**) or RoFMN (**b**) binding was determined. The change of fluorescence was also measured during the *in vitro* transcription process in the presence of 1 µM FMN (**c**) or 1 µM RoFMN (**d**). The observed fluorescence for each experiment was corrected to yield a plot where the initial signal was 1 (corresponding to the fluorescence of the free flavin).

In the subsequent experiment, fluorescence quenching induced by FMN or RoFMN was monitored during the formation of different riboswitch RNAs in the time course of transcription. FMN (1 µM) or RoFMN (1 µM) were added to an *in vitro* transcription assay, and fluorescence was measured for 30 min ([Figure 6](#gks616-F6){ref-type="fig"}c and d). The nascent riboswitch RNAs of *B. subtilis* and *S. coelicolor* induced fluorescence quenching in the presence of FMN and RoFMN indicating that both ligands are able to bind to nascent RNA molecules. However, in contrast to the completed RNA ([Figure 6](#gks616-F6){ref-type="fig"}a and b), the *S. davawensis ribB* riboswitch RNA as a nascent transcript was able to bind FMN but unable to bind RoFMN ([Figure 6](#gks616-F6){ref-type="fig"}c and d). This finding was perfectly in line with the results generated by the *in vitro* transcription/translation assays, which revealed that RoFMN, in contrast to FMN, did not negatively affect *S. davawensis* riboswitch function.

DISCUSSION
==========

*Streptomyces davawensis* is roseoflavin resistant to concentrations exceeding the level synthesized by *S. davawensis* under laboratory conditions. Moreover, RoFMN and RoFAD indeed are present in the cytoplasm of *S. davawensis* and also of *S. coelicolor* cells treated with roseoflavin. Our *in vitro* transcription/translation data suggest that in *S. davawensis* and in *S. coelicolor*, expression of the *rib* genes is controlled by the concentration of FMN present in the cytoplasm and that RoFMN (and not roseoflavin) triggers roseoflavin-sensitive FMN riboswitches. Interestingly, the *ribB* FMN riboswitches of *S. davawensis* and *S. coelicolor* were found to respond very differently with respect to the addition of RoFMN to *in vitro* transcription/translation assays: The *S. coelicolor ribB* FMN riboswitch was turned off by RoFMN. In contrast, the *S. davawensis ribB* FMN riboswitch provoked enhanced gene expression in the presence of RoFMN. Both riboswitches, however, were turned off by FMN. These *in vitro* results were strongly supported by our *in vivo* data, which showed that RibB activity was strongly reduced in *S. coelicolor* cells on treatment with roseoflavin but not in cells of *S. davawensis*. Furthermore, RoFMN was found to block the *S. coelicolor* FMN riboswitch more efficiently when compared with FMN (and also reduced RibB activity more strongly when compared with FMN), which explains why roseoflavin is able to inhibit growth and act as an antibiotic. Even if the supply with essential riboflavin/FMN/FAD would only be slightly reduced in the presence of roseoflavin, this may constitute a major disadvantage for competing cells in a natural habitat.

The critical residue responsible for the different responses of *S. davawensis* and of *S. coelicolor* to roseoflavin/RoFMN is nucleotide 61 present within the aptamer portion of the *ribB* FMN riboswitches. An A at nucleotide 61 (*S. davawensis*) accounts for roseoflavin resistance, a G or U at this position (*S. coelicolor*, *B. subtilis* and other *Streptomyces* species; [Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1)) results in roseoflavin sensitivity. Notably, the RoFMN-sensitive *ribA* FMN riboswitch of *S. davawensis* also contains a G at this critical position. We propose that nucleotide A61 within the *S. davawensis ribB* riboswitch aptamer specifically slows down RoFMN binding. Consequently, the sequestering RNA structure leading to reduced translation is not able to form which explains why *S. davawensis* is not sensitive to roseoflavin. In contrast, FMN binding is considerably faster, which explains why the *S. davawensis ribB* riboswitch is still regulated by FMN. Moreover, we propose that the downstream expression platform of the *S. davawensis ribB* riboswitch plays an important role with respect to the discrimination between FMN and RoFMN. Our fluorescence measurements suggest that the *S. davawensis* riboswitch is kinetically driven and remains receptive for modulator binding only in the relatively short time frame between aptamer formation and synthesis of the anti-ribosomal binding site stem. In contrast, the *S. coelicolor* riboswitch RNA seems to remain receptive to modulator binding for a longer time and thus is able to switch from the 'ON' to the 'OFF' mode at any time depending on whether FMN or RoFMN is present.

It is more difficult to find an explanation for the significantly increased activity of the *S. davawensis ribB* FMN riboswitch in the presence of RoFMN. Our fluorescence measurements argue against RoFMN binding to the complete riboswitch. In contrast, in-line probing data suggest tight binding of RoFMN to the aptamer portion under equilibrium conditions. Structural experiments will have to be carried out to resolve this apparent contradiction and possibly will reveal that RoFMN leads to a conformational change promoting access of the ribosomes to their binding site within the 5′-UTR of the *ribBMAH* mRNA.

Notably, roseoflavin-sensitive cells contain multiple targets for roseoflavin, FMN riboswitches and also flavoenzymes ([@gks616-B29]), which makes flavin analogs even more attractive as basic structures for developing novel antibacterial compounds. The current knowledge with respect to roseoflavin activity and resistance is summarized in [Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1).

Our work on roseoflavin underscores the potential generality of targeting riboswitches with new antibacterial drugs. Roseoflavin is a unique chemical being the only known natural compound negatively affecting riboswitches. As riboswitches are widespread in bacteria, we expect that a large number of highly interesting natural anti-infectives synthesized by yet unknown organisms remain to be discovered.
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[Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gks616/DC1) are available at NAR Online: Supplementary Tables 1--3 and Supplementary Figures 1--4.
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###### Supplementary Data

[^1]: RibB activity was determined in cell extracts of *S. coelicolor* and *S. davawenis* cultures. Cells were pregrown, washed, resuspended in fresh culture medium containing the indicated concentration of flavins and grown further. RibB activity was measured at different time points (20, 30 and 40 h) following the change of the culture medium and addition of flavins (riboflavin, RF; roseoflavin, RoF). For culturing the cells, either a minimal medium (MM) or a complex medium (YS) was used. The activities (µMol h^−1^) are presented per mg of total protein or normalized to 100% (control level). Mean values of three independent experiments are shown.
